Ítem
Solo Metadatos

Reaching a personalized medicine era: The dream of the drug market

Mostrar el registro sencillo de la publicación
dc.creatorBarajas-Gamboa J.S.spa
dc.creatorTarquino P.F.spa
dc.creatorPedraza J.E.spa
dc.creatorGonzalez-Nuñez D.spa
dc.date.accessioned2020-05-26T00:03:36Z
dc.date.available2020-05-26T00:03:36Z
dc.date.created2016spa
dc.description.abstractPersonalized medicine, the study of the influence of a patient’s genetic makeup on their disease susceptibility, prognosis, or treatment response (efficacy and safety), is actually in the spotlight. This field is expected to allow us to have effective and safe medication to targeted patients with appropriate genotypes. © 2016, JMN Medical Education Ltd. All rights reserved.eng
dc.format.mimetypeapplication/pdf
dc.identifier.issn17578515
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23610
dc.language.isoengspa
dc.publisherJMN Medical Education Ltdspa
dc.relation.citationIssueNo. 3
dc.relation.citationTitleBritish Journal of Medical Practitioners
dc.relation.citationVolumeVol. 9
dc.relation.ispartofBritish Journal of Medical Practitioners, ISSN:17578515, Vol.9, No.3 (2016)spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85011004979&partnerID=40&md5=b476bc773ab28c195b0115203ac04f7dspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordEstrogen receptorspa
dc.subject.keywordBreast cancerspa
dc.subject.keywordCastration resistant prostate cancerspa
dc.subject.keywordCdk12 genespa
dc.subject.keywordDisease predispositionspa
dc.subject.keywordDna repairspa
dc.subject.keywordDrug efficacyspa
dc.subject.keywordDrug industryspa
dc.subject.keywordDrug marketingspa
dc.subject.keywordDrug safetyspa
dc.subject.keywordEditorialspa
dc.subject.keywordFanca genespa
dc.subject.keywordGenetic disorderspa
dc.subject.keywordGeneticsspa
dc.subject.keywordGenomicsspa
dc.subject.keywordGenotypespa
dc.subject.keywordHealth care planningspa
dc.subject.keywordHealth care systemspa
dc.subject.keywordHormonal therapyspa
dc.subject.keywordHumanspa
dc.subject.keywordMedical researchspa
dc.subject.keywordPersonalized medicinespa
dc.subject.keywordPharmacogenomicsspa
dc.subject.keywordPractice guidelinespa
dc.subject.keywordPrepregnancy carespa
dc.subject.keywordPrognosisspa
dc.subject.keywordRad51b genespa
dc.subject.keywordSciencespa
dc.subject.keywordSingle nucleotide polymorphismspa
dc.subject.keywordTreatment outcomespa
dc.subject.keywordTreatment responsespa
dc.subject.keywordTumor suppressor genespa
dc.subject.keywordClinical outcomesspa
dc.subject.keywordDrug responsespa
dc.subject.keywordHuman genomicsspa
dc.subject.keywordPersonalized medicinespa
dc.subject.keywordPharmacogeneticsspa
dc.titleReaching a personalized medicine era: The dream of the drug marketspa
dc.typeothereng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaEditorialspa
Archivos
Colecciones
Artículos